1.
Systematic review with meta‐analysis: associations between coeliac disease and type 1 diabetes
by Elfström, P.
Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (10), p.1123-1132
2.
Nationwide prevalence of inflammatory bowel disease in Sweden: a population‐based register study
by Büsch, K.
Alimentary pharmacology & therapeutics, 2014-01, Vol.39 (1), p.57-68
3.
Predictors of persistent villous atrophy in coeliac disease: a population‐based study
by Lebwohl, B.
Alimentary pharmacology & therapeutics, 2014-03, Vol.39 (5), p.488-495
4.
Mucosal healing and mortality in coeliac disease
by Lebwohl, B.
Alimentary pharmacology & therapeutics, 2013-02, Vol.37 (3), p.332-339
5.
The characterisation and risk factors of ischaemic heart disease in patients with coeliac disease
by Emilsson, L.
Alimentary pharmacology & therapeutics, 2013-05, Vol.37 (9), p.905-914
6.
Coeliac disease and the risk of fractures – a general population‐based cohort study
by LUDVIGSSON, J. F.
Alimentary pharmacology & therapeutics, 2007-02, Vol.25 (3), p.273-285
8.
Coeliac disease and risk of tuberculosis: a population based cohort study
by Ludvigsson, J F
Thorax, 2007-01, Vol.62 (1), p.23-28
9.
Editorial: sprue‐like enteropathy due to olmesartan and other angiotensin receptor blockers – the plot thickens
by Lebwohl, B.
Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (10), p.1245-1246
10.
Allergy‐related diseases and recurrent abdominal pain during childhood – a birth cohort study
by Olén, O.
Alimentary pharmacology & therapeutics, 2014-12, Vol.40 (11-12), p.1349-1358
11.
Editorial: ‘brain fog’ and coeliac disease – evidence for its existence
by Lebwohl, B.
Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (5), p.565-565
12.
Editorial: mucosal healing and adherence to the gluten‐free diet in coeliac disease
by Lebwohl, B.
Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (10), p.1241-1242
13.
Commentary: coeliac disease and atherosclerosis – hand in hand?
by Ludvigsson, J. F.
Alimentary pharmacology & therapeutics, 2013-09, Vol.38 (5), p.549-550
14.
Risk of tuberculosis in a large sample of patients with coeliac disease – a nationwide cohort study
by Ludvigsson, J. F.
Alimentary pharmacology & therapeutics, 2011-03, Vol.33 (6), p.689-696
15.
IgA Deficiency & Mortality: A Population-Based Cohort Study
by Ludvigsson, J. F
Journal of clinical immunology, 2013-10-12, Vol.33 (8), p.1317-1324
16.
Commentary: coeliac disease, mortality and malignancy
by Ludvigsson, J. F.
Alimentary pharmacology & therapeutics, 2012-04, Vol.35 (7), p.839-840
17.
Registers of the Swedish total population and their use in medical research
by Ludvigsson, Jonas F
European journal of epidemiology, 2016-01-01, Vol.31 (2), p.125-136
18.
Letter: coeliac disease and ischaemic heart disease ‐ a true additional risk factor? Authors' reply
by Emilsson, L.
Alimentary pharmacology & therapeutics, 2013-06, Vol.37 (11), p.1118-1118
19.
Vascular disease in a population-based cohort of individuals hospitalised with coeliac disease
by Ludvigsson, J F
Heart (British Cardiac Society), 2007-09, Vol.93 (9), p.1111-1115
20.
A population‐based study of coeliac disease, neurodegenerative and neuroinflammatory diseases
by LUDVIGSSON, J. F.
Alimentary Pharmacology and Therapeutics, 2007-06, Vol.25 (11), p.1317-1327
